CIBC Boosts WELL Health Technologies (TSE:WELL) Price Target to C$5.25

WELL Health Technologies (TSE:WELL) had its price objective lifted by CIBC from C$5.00 to C$5.25 in a research note issued to investors on Friday,BayStreet.CA reports.

Separately, Ventum Financial dropped their target price on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research report on Tuesday, October 29th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, WELL Health Technologies currently has an average rating of “Moderate Buy” and an average target price of C$7.00.

WELL Health Technologies Trading Down 6.9 %

TSE:WELL opened at C$4.97 on Friday. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02. WELL Health Technologies has a one year low of C$3.41 and a one year high of C$5.38. The company has a market cap of C$1.24 billion, a PE ratio of 8.72, a PEG ratio of -1.93 and a beta of 1.20. The firm has a 50-day moving average of C$4.46 and a 200-day moving average of C$4.34.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.